Grey Fox Wealth Advisors’s Apyx Medical APYX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,993
Closed -$4.26K 163
2025
Q3
$4.26K Buy
+1,993
New +$4.22K ﹤0.01% 499
2023
Q2
Sell
-1,993
Closed -$5.74K 125
2023
Q1
$5.74K Hold
1,993
﹤0.01% 342
2022
Q4
$4.66K Buy
+1,993
New +$6.08K ﹤0.01% 318

Other funds holding APYX

Grey Fox Wealth Advisors's APYX Position: Q4 2025 in Review

Grey Fox Wealth Advisors sold out of Apyx Medical (APYX) in Q4 2025, closing a stake of 1,993 shares — an estimated $4.26K sold.

Grey Fox Wealth Advisors first reported a position in APYX in Q4 2022 and held it in 3 quarters. The position peaked at $5.74K in Q1 2023. 59 funds tracked by Wall St. Rank hold APYX as of Q4 2025.

  • Grey Fox Wealth Advisors reported no remaining Apyx Medical position as of Q4 2025 after selling out during the quarter.
  • Grey Fox Wealth Advisors sold 1,993 Apyx Medical shares in Q4 2025, an estimated $4.26K.
  • Grey Fox Wealth Advisors first reported a position in Apyx Medical in Q4 2022 and held it in 3 quarters.
  • Grey Fox Wealth Advisors's Apyx Medical position peaked at $5.74K in Q1 2023.
  • 59 funds tracked by Wall St. Rank held Apyx Medical as of Q4 2025.

Based on Grey Fox Wealth Advisors's 13F filing for Q4 2025, filed 12 Feb 2026.